Recombinant human follicle-stimulating hormone injection versus Gonal-f® in controlled ovarian stimulation for assisted reproductive technology: A multicenter, randomized, assessor-blind, active-controlled phase III trial
Recombinant human follicle-stimulating hormone injection versus Gonal-f® in controlled ovarian stimulation for assisted reproductive technology: A multicenter, randomized, assessor-blind, active-controlled phase III trial. // Experimental Cell Research. – URL: https://www.sciencedirect.com/science/article/pii/S0014482726003095?dgcid=rss_sd_all
Recombinant human follicle-stimulating hormone injection versus Gonal-f® in controlled ovarian stimulation for assisted reproductive technology: A multicenter, randomized, assessor-blind, active-controlled phase III trial. Experimental Cell Research. https://www.sciencedirect.com/science/article/pii/S0014482726003095?dgcid=rss_sd_all
“Recombinant human follicle-stimulating hormone injection versus Gonal-f® in controlled ovarian stimulation for assisted reproductive technology: A multicenter, randomized, assessor-blind, active-controlled phase III trial.” Experimental Cell Research.
@article{article3383,
title = {Recombinant human follicle-stimulating hormone injection versus Gonal-f® in controlled ovarian stimulation for assisted reproductive technology: A multicenter, randomized, assessor-blind, active-controlled phase III trial},
journal = {Experimental Cell Research},
url = {https://www.sciencedirect.com/science/article/pii/S0014482726003095?dgcid=rss_sd_all}
}